Literature DB >> 21776112

Heterogeneity in plasma homovanillic Acid levels in schizophreniform disorder.

N Pradhan1, C Harihar, P Das, C Andrade.   

Abstract

Plasma homovanillic acid (pHVA) levels were estimated in 20 cases of schizophreniform disorder, 14 cases of schizophrenia 'on medication' and 17 cases of schizophrenia 'off medication'. A bimodal distribution of pHVA was seen in schizophreniform disorder subjects, suggesting heterogenous groups in terms of dopaminergic function. No significant difference in the pHVA values was seen in the 3 groups, nor was there a relationship between the severity of the illness and the pHVA values; these results suggest plasticity of the dopaminergic system to neuroleptics.

Entities:  

Year:  1992        PMID: 21776112      PMCID: PMC2981046     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  16 in total

1.  Plasma HVA, neuroleptics, and dopaminergic plasticity.

Authors:  R Dávila
Journal:  Biol Psychiatry       Date:  1989-01       Impact factor: 13.382

2.  Estimates of dopamine and serotonin synthesis by the awake human brain.

Authors:  J W Maas; S E Hattox; N M Greene; D H Landis
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

3.  Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.

Authors:  D Pickar; R Labarca; M Linnoila; A Roy; D Hommer; D Everett; S M Paul
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

4.  Plasma homovanillic acid concentration and the severity of schizophrenic illness.

Authors:  K L Davis; M Davidson; R C Mohs; K S Kendler; B M Davis; C A Johns; Y DeNigris; T B Horvath
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

5.  Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.

Authors:  J W Maas; S A Contreras; E Seleshi; C L Bowden
Journal:  Arch Gen Psychiatry       Date:  1988-06

6.  Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection.

Authors:  W H Chang; M Scheinin; R S Burns; M Linnoila
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-10

7.  Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.

Authors:  M Davidson; M F Losonczy; R C Mohs; J C Lesser; P Powchik; L B Freed; B M Davis; V V Mykytyn; K L Davis
Journal:  Neuropsychopharmacology       Date:  1987-12       Impact factor: 7.853

8.  3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.

Authors:  N G Bacopoulos; S E Hattox; R H Roth
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

9.  Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.

Authors:  D Pickar; R Labarca; A R Doran; O M Wolkowitz; A Roy; A Breier; M Linnoila; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1986-07

10.  Plasma homovanillic acid levels and subtyping of schizophrenia.

Authors:  W H Chang; T Y Chen; C F Lee; J C Hung; W H Hu; E K Yeh
Journal:  Psychiatry Res       Date:  1988-03       Impact factor: 3.222

View more
  2 in total

1.  An overview of Indian research in schizophrenia.

Authors:  Parmanand Kulhara; Ruchita Shah; K R Aarya
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

2.  Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.